Clinical trial

Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

NCT03167411

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-05-24

PhasePHASE1

Study timeline

Study start (actual)2017-05-24Date precision: day

Registry last updated2021-05-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetes Mellitusunresolved

Interventions

BexagliflozinDRUG · verified · RxNorm: bexagliflozin

Exenatide InjectionDRUG

Sponsors & collaborators

Theracoslead sponsor

Mapped research locations

EvansvilleIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03167411 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.